Signal2026-06-29
ClinicalTrials.gov

[PHASE1] Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants

Part of

Phase 2 Clinical Trial Developments

Open primary sourceSee the whole picture